topical ghk-cu ENHANCED EXTENDS PEPTIDE PLATFORM WITH GHK-CU, FORMULATED UNDER MEDICAL COMMISSION OVERSIGHT GHK-Cu Rx Protocol

The IGF further stimulates the growth effects but also negatively feeds back to the hypothalamus

Anti-Aging and Skin Regeneration

This pause allows the peptide to disperse into tissue and prevents it from tracking back along the needle path

Community-derived FOXO4-DRI daily dosing ladder Week Weeks 1-4 Daily Dose 250 mcg Week Weeks 5-8 Daily Dose 375 mcg Week Weeks 9-12 Daily Dose 500 mcg Week Weeks 13-16 Daily Dose 500 mcg Reported community dosing only

Before approving a new drug, the FDA typically requires companies to conduct a type of study called a randomized controlled trial, in which study participants are allocated by chance to groups that either receive the drug, or are administered a placebo